Department of Pharmaceutical Technology, University of Szeged, Eötvös u. 6, 6720, Szeged, Hungary.
AAPS PharmSciTech. 2012 Dec;13(4):1341-7. doi: 10.1208/s12249-012-9861-9. Epub 2012 Sep 29.
The aim of this study was to investigate the influence of different processing methods on the profiles of 5-aminosalicylic acid dissolution from controlled-release matrix systems based on Eudragit® RL and Eudragit® RS water-insoluble polymers. The pure polymers and their mixtures were studied as matrix formers using different processing methods, i.e., direct compression, wet granulation of the active ingredient with the addition of polymer(s) to the external phase, wet granulation with water, and wet granulation with aqueous dispersions. In comparison with the directly compressed tablets, tablets made by wet granulation with water demonstrated a 6-19% increase in final drug dissolution, whereas when polymers were applied in the external phase during compression, a 0-13% decrease was observed in the amount of drug released. Wet granulation with aqueous polymer dispersions delayed the release of the drug; this was especially marked (a 54-56% decrease in drug release) in compositions, which contained a high amount of Eudragit RL 30D. The release profiles were mostly described by the Korsmeyer-Peppas model or the Hopfenberg model.
本研究旨在探讨不同加工方法对基于 Eudragit® RL 和 Eudragit® RS 水不溶性聚合物的控释基质系统中 5-氨基水杨酸释放特性的影响。采用不同的加工方法(如直接压片、活性成分与聚合物(s)的外相湿法制粒、水湿法制粒和水性分散体湿法制粒)研究了纯聚合物及其混合物作为基质形成剂。与直接压片相比,水湿法制粒制成的片剂最终药物溶出度提高了 6-19%,而在压缩过程中聚合物应用于外相时,药物释放量减少了 0-13%。水性聚合物分散体湿法制粒延迟了药物的释放;在含有高比例 Eudragit RL 30D 的制剂中,这一现象尤为明显(药物释放减少了 54-56%)。释放曲线主要用 Korsmeyer-Peppas 模型或 Hopfenberg 模型来描述。